NCT04482192View on ClinicalTrials.gov

Continuous Paravertebral Block by Intraoperative Direct Access Versus Systemic Analgesia for Postthoracotomy Pain Relief

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 15, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

March 31, 2020

Conditions
Post Thoracotomy Pain
Interventions
COMBINATION_PRODUCT

Thoracic paravertebral block

After ending pulmonary procedure, a pleural pouch created beside vertebral column, a catheter is inserted to the pouch for continuous infusion of 1% lidocaine for 3 postoperative days. Intravenous morphine sulfate (0.05mg/kg) was given as a rescue medication if the VAS ≥ 4.

DRUG

Systemic analgesia

Systemic analgesia (SA) group receive 1gm paracetamol and 30 mg ketorolac by intravenous infusion every 6 hours for 3 days. Intravenous morphine sulfate (0.05mg/kg) was given as a rescue medication if the VAS ≥ 4.

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04482192 - Continuous Paravertebral Block by Intraoperative Direct Access Versus Systemic Analgesia for Postthoracotomy Pain Relief | Biotech Hunter | Biotech Hunter